MétaCan
Menu
Back to cohort
Record W4380871404 · doi:10.1017/s0266462323000375

Uncertainty management in regulatory and health technology assessment decision-making on drugs: guidance of the HTAi-DIA Working Group

2023· review· en· W4380871404 on OpenAlexafffund
Milou A. Hogervorst, Rick A. Vreman, Inkatuuli Heikkinen, Indranil Bagchi, Iñaki Gutiérrez‐Ibarluzea, Bettina Ryll, Hans‐Georg Eichler, Elena Petelos, Sean Tunis, Claudine Sapède, Wim Goettsch, Rosanne Janssens, Isabelle Huys, Liese Barbier, Deirdre DeJean, Valentina Strammiello, D Lingri, Melinda Goodall, Magdalini Papadaki, Massoud Toussi, Despina Voulgaraki, Ania Mitan, Wija Oortwijn

Bibliographic record

VenueInternational Journal of Technology Assessment in Health Care · 2023
Typereview
Languageen
FieldEconomics, Econometrics and Finance
TopicHealth Systems, Economic Evaluations, Quality of Life
Canadian institutionsCanadian Agency for Drugs and Technologies in Health
FundersHealth Technology Assessment international
KeywordsDeliberationTransparency (behavior)Context (archaeology)StakeholderDecision support systemCategorizationManagement scienceConsistency (knowledge bases)Identification (biology)Process managementRisk analysis (engineering)Knowledge managementComputer scienceBusinessPolitical scienceData miningEngineeringPublic relations

Abstract

fetched live from OpenAlex

OBJECTIVES: Uncertainty is a fundamental component of decision making regarding access to and pricing and reimbursement of drugs. The context-specific interpretation and mitigation of uncertainty remain major challenges for decision makers. Following the 2021 HTAi Global Policy Forum, a cross-sectoral, interdisciplinary HTAi-DIA Working Group (WG) was initiated to develop guidance to support stakeholder deliberation on the systematic identification and mitigation of uncertainties in the regulatory-HTA interface. METHODS: Six online discussions among WG members (Dec 2021-Sep 2022) who examined the output of a scoping review, two literature-based case studies and a survey; application of the initial guidance to a real-world case study; and two international conference panel discussions. RESULTS: The WG identified key concepts, clustered into twelve building blocks that were collectively perceived to define uncertainty: "unavailable," "inaccurate," "conflicting," "not understandable," "random variation," "information," "prediction," "impact," "risk," "relevance," "context," and "judgment." These were converted into a checklist to explain and define whether any issue constitutes a decision-relevant uncertainty. A taxonomy of domains in which uncertainty may exist within the regulatory-HTA interface was developed to facilitate categorization. The real-world case study was used to demonstrate how the guidance may facilitate deliberation between stakeholders and where additional guidance development may be needed. CONCLUSIONS: The systematic approach taken for the identification of uncertainties in this guidance has the potential to facilitate understanding of uncertainty and its management across different stakeholders involved in drug development and evaluation. This can improve consistency and transparency throughout decision processes. To further support uncertainty management, linkage to suitable mitigation strategies is necessary.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.281
metaresearch head score (Gemma)0.235
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Review · Consensus signal: none
Teacher disagreement score0.281
Threshold uncertainty score0.887

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2810.235
Meta-epidemiology (narrow)0.0050.003
Meta-epidemiology (broad)0.0040.007
Bibliometrics0.0180.012
Science and technology studies0.0070.016
Scholarly communication0.0220.016
Open science0.0120.020
Research integrity0.0230.027
Insufficient payload (model declined to judge)0.0030.002

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.240
GPT teacher head0.535
Teacher spread0.295 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations21
Published2023
Admission routes2
Has abstractyes

Explore more

Same venueInternational Journal of Technology Assessment in Health CareSame topicHealth Systems, Economic Evaluations, Quality of LifeFrench-language works237,207